Tatva Chintan Pharma Chem Share Price Targets
Tatva Chintan Pharma Chem Limited | |||
 | Price: ₹1,044.80 (-2.2%) | ||
| 52 Week Low: ₹621.00 52 Week High: ₹1,232.75 | |||
| Market Capital: 2,611.95 Crore (Smallcap) | |||
| Basic Materials -> Specialty Chemicals | |||
Tatva Chintan Pharma Chem Stock Comparison: Tatva Chintan Pharma Chem vs Polyplex Corporation | Tatva Chintan Pharma Chem vs Thirumalai | Tatva Chintan Pharma Chem vs Premier Explosives | Tatva Chintan Pharma Chem vs Vardhman Special Steels | Tatva Chintan Pharma Chem vs S H Kelkar and | Tatva Chintan Pharma Chem vs Sanghi Industries | |||
Show Table of Contents
Table of Contents
Tatva Chintan Pharma Chem Recent Performance
Over the past 435 trading days, the value of Tatva Chintan Pharma Chem's stock has lost ₹458.80 (-30.51%). On 07 Nov 2023, one share was worth ₹1503.60 and by 14 Aug 2025, the value dropped to ₹1044.80. During this period it created a highest high of ₹1650.85 and lowest low of ₹621.00.
Tatva Chintan Pharma Chem Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 1182 (+13.13%) | Price Action: 28 Jul 2025 High |
| Tomorrow Target 2 | 1165.2 (+11.52%) | Price Action: 05 Aug 2025 High |
| Tomorrow Target 1 | 1142.4 (+9.34%) | Price Action: 06 Aug 2025 High |
| Current Price | 1044.80 | Tatva Chintan Pharma Chem's share price as of 14 Aug 2025 |
| Stop Loss 1 | 958.8 (-8.24%) | Price Action: 12 Jun 2025 High |
| Stop Loss 2 | 948.35 (-9.24%) | Price Action: 06 Jun 2025 High |
| Stop Loss 3 | 937 (-10.32%) | Price Action: 09 Jun 2025 Low |
Summary
14 Aug 2025: Tatva Chintan Pharma Chem finished the day at ₹1044.80, losing ₹-23.50 (-2.20%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -10.32% to 13.13% with:
- Target prices: ₹1142.4 to ₹1182
- Support levels: ₹958.8 to ₹937
- Recent high: ₹1069.70
- Recent low: ₹1031.50
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Tatva Chintan Pharma Chem Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 1092.25 (+4.54%) | Fibonacci Extension Level 50.00% |
| Next Week Target 2 | 1081.2 (+3.48%) | Price Action: 08 Aug 2025 High |
| Next Week Target 1 | 1066.5 (+2.06%) | Price Action: 18 Jul 2025 High |
| Current Price | 1044.80 | Tatva Chintan Pharma Chem's share price as of 14 Aug 2025 |
| Stop Loss 1 | 1037.55 (-0.7%) | Price Action: 23 Jul 2025 High |
| Stop Loss 2 | 1024 (-2%) | Price Action: 24 Jul 2025 High |
| Stop Loss 3 | 998.1 (-4.47%) | Price Action: 04 Jul 2025 Low |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -4.47% to 4.54% with:
- Upper targets: ₹1066.5 to ₹1092.25
- Support levels: ₹1037.55 to ₹998.1
Tatva Chintan Pharma Chem Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 1197.49 (+14.61%) | Price Action: Jul 2024 High |
| Next Month Target 2 | 1182 (+13.13%) | Price Action: 28 Jul 2025 High |
| Next Month Target 1 | 1165.2 (+11.52%) | Price Action: 05 Aug 2025 High |
| Current Price | 1044.80 | Tatva Chintan Pharma Chem's share price as of 14 Aug 2025 |
| Stop Loss 1 | 999.06 (-4.38%) | Fibonacci Retracement Level 38.20% |
| Stop Loss 2 | 988 (-5.44%) | Price Action: 10 Jun 2025 High |
| Stop Loss 3 | 978 (-6.4%) | Price Action: May 2025 High |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -6.39% to 14.61% with:
- Target range: ₹1165.2 to ₹1197.49
- Support levels: ₹999.06 to ₹978
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
